Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving postoperative outcomes in gynecologic oncology through a standardized telehealth intervention: experience from an urban safety-net hospital system.

Gynecologic oncology reports·2026
Same author

EMoMiS: A pipeline for epitope-based molecular mimicry search in protein structures with potential applications to SARS-CoV-2.

Computational and structural biotechnology journal·2026
Same author

Exploring Speech Biosignatures for Traumatic Brain Injury and Neurodegeneration: Pilot Machine Learning Study.

JMIR neurotechnology·2025
Same author

GPS and Smartphone Technology for Real-World Measurement of Community Mobility in Healthcare.

Digital biomarkers·2025
Same author

Documentation of patient withdrawals, retention strategies, and postwithdrawal data practices in cancer clinical trials.

Cancer·2025
Same author

A Proof-of-Concept Development on Speech Analysis for Concussion Detection.

Studies in health technology and informatics·2025
Same journal

Movi Color: fast and accurate taxonomic classification with the move structure.

ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine·2026
Same journal

Privacy-Preserving Collaborative Population Stratification with Dynamic Algorithm and Hyperparameter Selection.

ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine·2026
Same journal

A Comparison of Combined P-value Methods for Gene Differential Expression Using RNA-Seq Data.

ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine·2026
Same journal

Enhancing Agent-Based Models with Real-Time Movement Data to Assess Impacts of Biosecurity Interventions on Disease Exposure in Healthcare Settings.

ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine·2026
Same journal

Evaluating Drug Effectiveness for Antihypertensives in Heart Failure Prognosis: Leveraging Composite Clinical Endpoints and Biomarkers from Electronic Health Records.

ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine·2026
Same journal

AlphaFold2 Model Refinement Using Structure Decoys.

ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

MADSurv: An Uncertainty-Aware Framework for Multimodal Cancer Survival Analysis.

Enshi Zhang1, Varun Sai Raigir2, Christian Poellabauer1

  • 1Florida International University, Miami, Florida, USA.

ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine
|June 15, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces the Modality-Aware Discrete-Time Survival (MADSurv) framework for cancer survival prediction. MADSurv intelligently fuses patient data from multiple sources, providing more accurate survival probability estimates over time.

Keywords:
Cancer survival analysismultimodal learningprognostic modeling

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Related Experiment Videos

Last Updated: Jun 16, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

  • Oncology
  • Biomedical Informatics
  • Machine Learning

Background:

  • Multimodal learning enhances cancer survival prediction using clinical, imaging, and genomic data.
  • Existing methods often fail to account for data conflicts or unreliability across modalities.
  • Current models typically provide relative risk scores, lacking precise survival probability estimates.

Purpose of the Study:

  • To develop a novel framework, MADSurv, for improved cancer survival prediction.
  • To address limitations in data fusion and the inability of current models to quantify survival likelihood.
  • To enable more personalized and clinically relevant cancer risk assessment.

Main Methods:

  • Proposed the Modality-Aware Discrete-Time Survival (MADSurv) framework.
  • Implemented an uncertainty-aware attention mechanism for intelligent, confidence-based data fusion.
  • Enabled predictions of survival probabilities at discrete yearly intervals, not just relative risk.

Main Results:

  • MADSurv demonstrated superior and competitive performance across five cancer datasets.
  • The uncertainty-aware attention mechanism improved robustness and personalization by prioritizing reliable modalities.
  • The model accurately estimated survival probabilities at yearly milestones, validated by Brier scores.

Conclusions:

  • MADSurv offers a more robust and personalized approach to cancer survival prediction.
  • The framework enhances clinical utility by providing quantifiable survival probabilities over time.
  • This work advances multimodal learning for improved cancer outcome assessment.